 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [34mDoes DIAZEPAM increase or decrease the risk of hip fracture?[0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.AGENT [0m
*[1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mrecipient_message[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"recipient_message"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"intended_recipient"[0m[32m: [0m[32m"FDAHandler"[0m[32m,[0m
[32m    [0m[32m"content"[0m[32m: [0m[32m"Does DIAZEPAM increase or decrease the risk of hip fracture?"[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [37m Entity.AGENT [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [32mDoes DIAZEPAM increase or decrease the risk of hip fracture?[0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0mEntity.LLM[1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m[[0m[32mCANNOT RESPOND[0m[1;32m][0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [34mDoes DIAZEPAM increase or decrease the risk of hip fracture?[0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.AGENT [0m
*[1m([0mFDAHandler[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mrelevant_search_extracts[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"relevant_search_extracts"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"query"[0m[32m: [0m[32m"Does DIAZEPAM increase the risk of hip fracture?"[0m[32m,[0m
[32m    [0m[32m"drug"[0m[32m: [0m[32m"diazepam"[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0mFDAHandler[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mrelevant_search_extracts[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Below are some relevant extracts for your query:[0m
[31m        -----[0m
[31m        [0m
[31mCONTENT: DIAZEPAM: risks: Risk Summary Neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [0m[1;31m([0m[31msee WARNINGS: [0m
[31mNeonatal Sedation and Withdrawal Syndrome and Clinical Considerations [0m[1;31m)[0m[31m. Available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear [0m
[31massociation with benzodiazepines and major birth defects [0m[1;31m([0m[31msee Data [0m[1;31m)[0m[31m. Diazepam has been shown to be teratogenic in mice and hamsters when given orally at daily doses of [0m[1;31m100[0m[31m mg/kg or greater [0m
[1;31m([0m[31mapproximately eight times the maximum recommended human dose [0m[1;31m[[0m[31mMRHD[0m[31m=[0m[1;31m1[0m[31m mg/kg/day[0m[1;31m][0m[31m or greater on a mg/m [0m[1;31m2[0m[31m basis[0m[1;31m)[0m[31m. Cleft palate and encephalopathy are the most common and consistently reported [0m
[31mmalformations produced in these species by administration of high, maternally toxic doses of diazepam during organogenesis. The background risk of major birth defects and miscarriage for the indicated[0m
[31mpopulation is unknown. DIAZEPAM: risks: All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated risk of major birth [0m
[31mdefects and of miscarriage in clinically recognized pregnancies is [0m[1;31m2[0m[31m% to [0m[1;31m4[0m[31m% and [0m[1;31m15[0m[31m% to [0m[1;31m20[0m[31m%, respectively.         [0m
[31mSOUR[0m[1;31mCE:D[0m[31mIAZEPAM label[0m


[31mCONTENT: DIAZEPAM: precautions: Cleft palate and encephalopathy are the most common and consistently reported malformations produced in these species by administration of high, maternally toxic doses [0m
[31mof diazepam during organogenesis. Rodent studies have indicated that prenatal exposure to diazepam doses similar to those used clinically can produce long-term changes in cellular immune responses, [0m
[31mbrain neurochemistry, and behavior. Nursing Mothers Diazepam is present in breastmilk. There are reports of sedation, poor feeding, and poor weight gain in infants exposed to benzodiazepines through [0m
[31mbreast milk. Because of the potential for serious adverse reaction, including sedation and withdrawal symptoms in breastfed infants, advise patient that breastfeeding is not recommended during [0m
[31mtreatment with diazepam tablets. Pediatric Use Safety and effectiveness in pediatric patients below the age of [0m[1;31m6[0m[31m months have not been established. DIAZEPAM: precautions: Geriatric Use In elderly [0m
[31mpatients, it is recommended that the dosage be limited to the smallest effective amount to preclude the development of ataxia or oversedation [0m[1;31m([0m[1;31m2[0m[31m mg to [0m[1;31m2.5[0m[31m mg once or twice daily, initially to be [0m
[31mincreased gradually as needed and tolerated[0m[1;31m)[0m[31m. Extensive accumulation of diazepam and its major metabolite, desmethyldiazepam, has been noted following chronic administration of diazepam in healthy [0m
[31melderly male subjects. Metabolites of this drug are known to be substantially excreted by the kidney, and the risk of toxic reactions may be greater in patients with impaired renal function. Because [0m
[31melderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. Hepatic Insufficiency Decreases in clearance [0m
[31mand protein binding, and increases in volume of distribution and half-life have been reported in patients with cirrhosis. DIAZEPAM: precautions: In such patients, a [0m[1;31m2[0m[31m- to [0m[1;31m5[0m[31m-fold increase in mean [0m
[31mhalf-life has been reported. Delayed elimination has also been reported for the active metabolite desmethyldiazepam. Benzodiazepines are commonly implicated in hepatic encephalopathy. Increases in [0m
[31mhalf-life have also been reported in hepatic fibrosis and in both acute and chronic hepatitis [0m[1;31m([0m[31msee CLINICAL PHARMACOLOGY: Pharmacokinetics in Special Populations: Hepatic Insufficiency [0m[1;31m)[0m[31m.         [0m
[31mSOUR[0m[1;31mCE:D[0m[31mIAZEPAM label[0m


[31mCONTENT: DIAZEPAM: openfda: pharm_class_cs         [0m
[31mSOUR[0m[1;31mCE:D[0m[31mIAZEPAM label[0m


[31mCONTENT: DIAZEPAM: carcinogenesis_and_mutagenesis_and_impairment_of_fertility: Carcinogenesis, Mutagenesis, Impairment of Fertility In studies in which mice and rats were administered diazepam in the [0m
[31mdiet at a dose of [0m[1;31m75[0m[31m mg/kg/day [0m[1;31m([0m[31mapproximately [0m[1;31m6[0m[31m and [0m[1;31m12[0m[31m times, respectively, the maximum recommended human dose [0m[1;31m[[0m[31mMRHD = [0m[1;31m1[0m[31m mg/kg/day[0m[1;31m][0m[31m on a mg/m [0m[1;31m2[0m[31m basis[0m[1;31m)[0m[31m for [0m[1;31m80[0m[31m and [0m[1;31m104[0m[31m weeks, respectively, an increased [0m
[31mincidence of liver tumors was observed in males of both species. The data currently available are inadequate to determine the mutagenic potential of diazepam. Reproduction studies in rats showed [0m
[31mdecreases in the number of pregnancies and in the number of surviving offspring following administration of an oral dose of [0m[1;31m100[0m[31m mg/kg/day [0m[1;31m([0m[31mapproximately [0m[1;31m16[0m[31m times the MRHD on a mg/m [0m[1;31m2[0m[31m basis[0m[1;31m)[0m[31m prior to [0m
[31mand during mating and throughout gestation and lactation. DIAZEPAM: carcinogenesis_and_mutagenesis_and_impairment_of_fertility: No adverse effects on fertility or offspring viability were noted at a [0m
[31mdose of [0m[1;31m80[0m[31m mg/kg/day [0m[1;31m([0m[31mapproximately [0m[1;31m13[0m[31m times the MRHD on a mg/m [0m[1;31m2[0m[31m basis[0m[1;31m)[0m[31m.         [0m
[31mSOUR[0m[1;31mCE:D[0m[31mIAZEPAM label[0m


[31mCONTENT: DIAZEPAM: spl_medguide_table: content> [0m[1;31m<[0m[1;31mcontent[0m[31m [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>Call your healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry [0m
[31myou:<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mitem[0m[31m><[0m[31m/[0m[31mlist[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m[31mstyleCode[0m[31m=[0m[31m"Lrule[0m[31m "[0m[31m [0m[31mvalign[0m[31m=[0m[31m"top"[0m[31m><list [0m[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>thoughts about suicide or [0m
[31mdying<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>new or worse depression<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>feeling agitated or restless<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>trouble sleeping [0m
[1;31m([0m[31minsomnia[0m[1;31m)[0m[31m<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>acting aggressive, being angry, or violent<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>other unusual changes in behavior or [0m
[31m<paragraph>mood<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mitem[0m[31m><[0m[31m/[0m[31mlist[0m[31m><[0m[31m/[0m[31mtd[0m[31m><td [0m[31mstyleCode[0m[31m=[0m[31m"Rrule[0m[31m DIAZEPAM: spl_medguide_table: "[0m[31m [0m[31mvalign[0m[31m=[0m[31m"top"[0m[31m><list [0m[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>attempts to commit [0m
[31msuicide<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>new or worse anxiety or irritability<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>an extreme increase in activity and talking [0m
[1;31m([0m[31mmania[0m[1;31m)[0m[31m<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>new or worse panic attacks<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>acting on dangerous impulses<[0m[31m/[0m[31mitem[0m[31m><[0m[31m/[0m[31mlist[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m[31mcolspan[0m[31m=[0m[31m"2"[0m[31m [0m
[31mstyleCode[0m[31m=[0m[31m"Rrule[0m[31m Lrule "[0m[31m [0m[31mvalign[0m[31m=[0m[31m"top"[0m[31m><paragraph><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>How can I watch for early symptoms of suicidal thoughts and actions?<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><list [0m
[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. DIAZEPAM: spl_medguide_table: [0m
[31m<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>Keep all follow-up visits with your healthcare provider as scheduled. <[0m[31m/[0m[31mitem[0m[31m><[0m[31m/[0m[31mlist[0m[31m><paragraph>Call your healthcare provider between visits as needed, [0m
[31mespecially if you are worried about symptoms.<[0m[31m/[0m[31mparagraph[0m[31m><paragraph>Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare[0m
[31mprovider may check for other causes. DIAZEPAM: spl_medguide_table: <[0m[31m/[0m[31mparagraph[0m[31m><paragraph><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>The most common side effects of diazepam tablets include:<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><list[0m
[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>drowsiness<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>muscle weakness<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>loss of control of body movements [0m
[1;31m([0m[31mataxia[0m[1;31m)[0m[31m<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>fatigue<[0m[31m/[0m[31mitem[0m[31m><[0m[31m/[0m[31mlist[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m[31mcolspan[0m[31m=[0m[31m"2"[0m[31m [0m[31mstyleCode[0m[31m=[0m[31m"Rrule[0m[31m Lrule Botrule "[0m[31m [0m[31mvalign[0m[31m=[0m[31m"top"[0m[31m><paragraph>These are not all the possible side effects [0m
[31mof diazepam tablets. <content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>Call your doctor for medical advice about side effects. You may report side effects to FDA at [0m[1;31m1[0m[31m-[0m[1;31m800[0m[31m-FDA-[0m[1;31m1088[0m[31m. DIAZEPAM: spl_medguide_table: [0m
[31mcontent><[0m[31m/[0m[31mparagraph[0m[31m><paragraph>You may also report side effects to Mylan at [0m[1;31m1[0m[31m-[0m[1;31m877[0m[31m-[0m[1;31m446[0m[31m-[0m[1;31m3679[0m[31m [0m[1;31m([0m[1;31m1[0m[31m-[0m[1;31m877[0m[31m-[0m[1;31m4[0m[31m-INFO-RX[0m[1;31m)[0m[31m.<[0m[31m/[0m[31mparagraph[0m[31m><[0m[31m/[0m[31mtd[0m[31m><[0m[31m/[0m[31mtr[0m[31m><tr><td [0m[31mcolspan[0m[31m=[0m[31m"2"[0m[31m [0m[31mstyleCode[0m[31m=[0m[31m"Rrule[0m[31m Lrule Toprule Botrule "[0m[31m [0m
[31mvalign[0m[31m=[0m[31m"top"[0m[31m><paragraph><content [0m[31mstyleCode[0m[31m=[0m[31m"bold"[0m[31m>How should I store diazepam tablets?<[0m[31m/[0m[31mcontent[0m[31m><[0m[31m/[0m[31mparagraph[0m[31m><list [0m[31mlistType[0m[31m=[0m[31m"unordered"[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[31m>Store diazepam tablets in a [0m
[31mtightly closed container at room temperature between [0m[1;31m20[0m[31m&#xB0; to [0m[1;31m25[0m[31m&#xB0;C [0m[1;31m([0m[1;31m68[0m[31m&#xB0; to [0m[1;31m77[0m[31m&#xB0;F[0m[1;31m)[0m[31m. Protect from light.<[0m[31m/[0m[31mitem[0m[31m><item><caption>&#x2022;<[0m[31m/[0m[31mcaption[0m[1;31m>[0m[31mKeep diazepam tablets and all medicines [0m
[31mout of the reach of children.         [0m
[31mSOUR[0m[1;31mCE:D[0m[31mIAZEPAM label[0m

[31m        -----[0m
[31m        If NONE of the extracts are relevant, try doing a web search with the[0m
[31m        `relevant_search_extracts` tool/function-call[0m
[31m        [0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.USER [0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [32m DO-NOT-KNOW[0m
*[1m([0mFDAHandler[1m)[0m [37m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [34mDO-NOT-KNOW[0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.AGENT [0m
*[1m([0mFDAHandler[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mrelevant_search_extracts[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"relevant_search_extracts"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"query"[0m[32m: [0m[32m"Does DIAZEPAM increase the risk of hip fracture?"[0m[32m,[0m
[32m    [0m[32m"drug"[0m[32m: [0m[32m"diazepam"[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0mFDAHandler[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mrelevant_search_extracts[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31mNo relevant extracts found for Does DIAZEPAM increase the risk of hip fracture?[0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.USER [0m
 [1m([0mFDAHandler[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0mFDAHandler[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m<[0m[1;32mDONE[0m[1;32m>[0m[32m DO-NOT-KNOW[0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m FDAHandler [0m [1;34mEntity.USER[0m[1m([0mFDAHandler[1m)[0m [1m([0m=>       LLM[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [34mDO-NOT-KNOW[0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Critic [0m [1;34mEntity.USER[0m[1m([0m    Critic[1m)[0m [1m([0m=>FDAHandler[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
*[1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [37m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [34mDO-NOT-KNOW[0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.AGENT [0m
*[1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [32mI have asked FDAHandler for information regarding whether DIAZEPAM increases [0m
[32mor decreases the risk of hip fracture. However, FDAHandler has responded with DO-NOT-KNOW, indicating that the FDA label for DIAZEPAM does not contain information specific to the risk of hip fracture [0m
[32massociated with its use.[0m

[32mGiven this response, I am unable to provide a definitive answer based on FDA label data. Therefore, my final answer must also be DO-NOT-KNOW. The FDA label data does not specify whether DIAZEPAM [0m
[32mincreases or decreases the risk of hip fracture.[0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.USER [0m
*[1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0m          [1m)[0m [1m([0m=>       LLM[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Do one of the following:[0m

[31m        [0m[1;31m1[0m[31m. If you intend to ask a question to FDAAgent:[0m
[31m            Please use the [0m[31m'add_recipient'[0m[31m tool/function-call[0m
[31m            and specify FDAAgent as your `intended_recipient`.[0m
[31m            DO NOT REPEAT your original message; ONLY specify the [0m
[31m            `intended_recipient` via this tool/function-call.[0m
[31m        [0m[1;31m2[0m[31m. If you are ready to have the critic check your answer,[0m
[31m            do so with the `final_answer` tool/function, as I have requested.[0m
[31m        [0m[1;31m3[0m[31m. If the critic is satisfied and you intend to submit your final answer,[0m
[31m            answer as I have requested, making sure to mark that you are done as usual.[0m

[31m        When you have decided and stated your answer [0m[1;31m([0m[31mor lack of one[0m[1;31m)[0m[31m, you must[0m
[31m        ALWAYS specify that you are done using the usual code.[0m

[31m        DO NOT simply acknowldedge these instructions. If you have nothing[0m
[31m        else to say, you MUST EXIT IMMEDIATELY by stating that you are done[0m
[31m        with the usual code [0m[1;31m([0m[31mas in #[0m[1;31m3[0m[1;31m)[0m[31m.[0m
[31m        [0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0mEntity.USER[1m)[0m [1m([0m=>       LLM[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>       LLM[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"final_answer"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"question"[0m[32m: [0m[32m"Does DIAZEPAM increase or decrease the risk of hip fracture?"[0m[32m,[0m
[32m    [0m[32m"steps"[0m[32m: [0m[1;32m[[0m
[32m      [0m[32m"I asked FDAHandler if DIAZEPAM increases or decreases the risk of hip fracture."[0m[32m,[0m
[32m      [0m[32m"FDAHandler responded with DO-NOT-KNOW, indicating that the FDA label for DIAZEPAM does not contain information specific to the risk of hip fracture."[0m
[32m    [0m[1;32m][0m[32m,[0m
[32m    [0m[32m"answer"[0m[32m: [0m[32m"DO-NOT-KNOW"[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31m__PASS__:Critic[0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0mEntity.LLM[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m[[0m[32mCANNOT RESPOND[0m[1;32m][0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m FDAHandler [0m [1;34mEntity.USER[0m[1m([0mFDAHandler[1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;34m[[0m[34mCANNOT RESPOND[0m[1;34m][0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m [1;34mEntity.USER[0m[1m([0m          [1m)[0m [1m([0m=>    Critic[1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0mfinal_answer[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"final_answer"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"question"[0m[34m: [0m[34m"Does DIAZEPAM increase or decrease the risk of hip fracture?"[0m[34m,[0m
[34m    [0m[34m"steps"[0m[34m: [0m[1;34m[[0m
[34m      [0m[34m"I asked FDAHandler if DIAZEPAM increases or decreases the risk of hip fracture."[0m[34m,[0m
[34m      [0m[34m"FDAHandler responded with DO-NOT-KNOW, indicating that the FDA label for DIAZEPAM does not contain information specific to the risk of hip fracture."[0m
[34m    [0m[1;34m][0m[34m,[0m
[34m    [0m[34m"answer"[0m[34m: [0m[34m"DO-NOT-KNOW"[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"final_answer"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mfinal_answer[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m 
[31m        Question: Does DIAZEPAM increase or decrease the risk of hip fracture?[0m
[31m        -----[0m
[31m        Reasoning:[0m
[31m        [0m[1;31m1[0m[31m. I asked FDAHandler if DIAZEPAM increases or decreases the risk of hip fracture.[0m
[1;31m2[0m[31m. FDAHandler responded with DO-NOT-KNOW, indicating that the FDA label for DIAZEPAM does not contain information specific to the risk of hip fracture.[0m
[31m        -----[0m
[31m        Final answer: DO-NOT-KNOW[0m
[31m        [0m
 [1m([0mCritic[1m)[0m [31m Entity.USER [0m
 [1m([0mCritic[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [32mFUNC: [0m[1;32m{[0m
[32m  [0m[32m"name"[0m[32m: [0m[32m"feedback"[0m[32m,[0m
[32m  [0m[32m"to"[0m[32m: [0m[32m""[0m[32m,[0m
[32m  [0m[32m"arguments"[0m[32m: [0m[1;32m{[0m
[32m    [0m[32m"critique"[0m[32m: [0m[32m""[0m
[32m  [0m[1;32m}[0m
[1;32m}[0m
*[1m([0mCritic[1m)[0m [37m Entity.LLM [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m<[0m[1;31mDONE[0m[1;31m>[0m[31m __PASS__[0m
*[1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [37m Critic [0m [1;34mEntity.USER[0m[1m([0m    Critic[1m)[0m [1m([0m=>     AGENT[1m)[0m [1m([0mX           [1m)[0m   [1;35mFUNC[0m[1m([0m  feedback[1m)[0m [34mFUNC: [0m[1;34m{[0m
[34m  [0m[34m"name"[0m[34m: [0m[34m"feedback"[0m[34m,[0m
[34m  [0m[34m"to"[0m[34m: [0m[34m""[0m[34m,[0m
[34m  [0m[34m"arguments"[0m[34m: [0m[1;34m{[0m
[34m    [0m[34m"critique"[0m[34m: [0m[34m""[0m[34m,[0m
[34m    [0m[34m"request"[0m[34m: [0m[34m"feedback"[0m
[34m  [0m[1;34m}[0m
[1;34m}[0m
*[1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [37m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0m  feedback[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [31mYour reasoning is valid, no feedback was provided.[0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.USER [0m
 [1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [31m Entity.AGENT [0m [1;31mEntity.AGENT[0m[1m([0mEntity.AGENT[1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;31m[[0m[31mCANNOT RESPOND[0m[1;31m][0m
*[1m([0morchestrator-hip fracture-DIAZEPAM[1m)[0m [37m Entity.LLM [0m [1;32mEntity.LLM[0m[1m([0m          [1m)[0m [1m([0m=>          [1m)[0m [1m([0mX           [1m)[0m       [1m([0m          [1m)[0m [1;32m<[0m[1;32mDONE[0m[1;32m>[0m[32m DO-NOT-KNOW[0m

[32mThe FDA label data does not specify whether DIAZEPAM increases or decreases the risk of hip fracture, and therefore I cannot provide a definitive answer based on this data.[0m
